Cargando…
Reversing oncogenic transformation with iron chelation
Cancer cells accumulate iron to supplement their aberrant growth and metabolism. Depleting cells of iron by iron chelators has been shown to be selectively cytotoxic to cancer cells in vitro and in vivo. Iron chelators are effective at combating a range of cancers including those which are difficult...
Autores principales: | Abdelaal, Gina, Veuger, Stephany |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825639/ https://www.ncbi.nlm.nih.gov/pubmed/33520115 http://dx.doi.org/10.18632/oncotarget.27866 |
Ejemplares similares
-
Novel iron chelator SK4 demonstrates cytotoxicity in a range of tumour derived cell lines
por: Abdelaal, Gina, et al.
Publicado: (2022) -
Novel Iron Chelator SK4 Drives Cytotoxicity through Inhibiting Mitochondrial Metabolism in Ovarian and Triple Negative Breast Cancer Cell Lines
por: Abdelaal, Gina, et al.
Publicado: (2023) -
Iron Chelators in Treatment of Iron Overload
por: Entezari, Sarina, et al.
Publicado: (2022) -
Iron Chelation in Local Infection
por: Scott, Cassidy, et al.
Publicado: (2021) -
Iron chelation and multiple sclerosis
por: Weigel, Kelsey J., et al.
Publicado: (2014)